AM Rx vs Effecty
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Patients with insurance seeking brand-name GLP-1 access (review regulatory warnings carefully).
- semaglutide
- $151/moquarterly term
- tirzepatide
- Not confirmed for AM Rx.
FDAWarning letter issued to FitRX, LLC dba AM RX in June 2026. See the FDA warning-letter database.
Before enrolling
Active FTC/DOJ lawsuit over deceptive billing and subscription practices
Desk Score
Patients who want affordable brand-capable care nationwide without extra program layers.
- semaglutide
- $160/mo
- tirzepatide
- $240/mo
Before enrolling
Injectable only — no oral route
Our review of Effecty gives it 89/100 (B+), while our review of AM Rx gives it 42/100 (C). The score breakdown shows where each provider does better.
Desk Score, dimension by dimension
Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.
42/100
C
89/100
B+
The spec sheet
Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.
| Field | AM Rx | Effecty |
|---|---|---|
| Semaglutide | $151/moquarterly termFull plan terms$151/mo (quarterly plan, plus a separate fee, compounded) | $160/moFull plan terms$160/mo |
| Tirzepatide | Not confirmed for AM Rx. | $240/moFull plan terms$240/mo |
| Coverage | Not confirmed for AM Rx. | All 50 states |
| Brand-name | Brand-name option listed | Brand-name option listed |
| Oral option | Not confirmed here | Not confirmed here |
| Best for | Patients with insurance seeking brand-name GLP-1 access (review regulatory warnings carefully). | Patients who want affordable brand-capable care nationwide without extra program layers. |
| Desk Score | 42/100C | 89/100B+ |
The verdict
Desk pick — EffectyEffecty has the higher Desk Score, but AM Rx may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.
Patients with insurance seeking brand-name GLP-1 access (review regulatory warnings carefully).
FDAWarning letter issued to FitRX, LLC dba AM RX in June 2026. See the FDA warning-letter database.
Patients who want affordable brand-capable care nationwide without extra program layers.
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. Both compounded injections with dose-independent advertised rates. The $79 and $129 monthly equivalents require a year paid in full; confirm the total charge and refund terms.
More head-to-heads
- AM Rx vs CoreAge Rx
- CoreAge Rx vs Effecty
- AM Rx vs Vytora Health
- Effecty vs Ondra Health
- AgelessRx vs AM Rx
- Effecty vs Vytora Health
Or see the full comparison hub and the complete ranking.